-
Recent reports reveal that for the first time, more children aged 5-19 are obese than underweight, driven by ultra-processed foods and marketing. Data from UNICEF, WHO, and national surveys show rising obesity rates worldwide, with significant health risks and calls for policy action.
-
Recent UK regulations restrict free refills of sugary drinks in hospitality venues and ban multi-buy deals on unhealthy foods to combat rising obesity. These measures, effective from October 2025, aim to promote healthier choices and reduce health risks like diabetes and heart disease, amid ongoing industry adjustments.
-
On December 1-2, 2025, WHO issued its first guidelines recommending long-term use of GLP-1 drugs like Wegovy and Mounjaro for obesity treatment, recognizing obesity as a chronic disease. The US government finalized deals lowering prices for these drugs under Medicare and Medicaid, expanding coverage to more patients. Despite benefits, studies show weight and health gains reverse if treatment stops, highlighting need for ongoing care.